Domenica Lorusso

ScholarGPS® ID: 16911851842887

Affiliation

Università Cattolica del Sacro Cuore, Milan , Brescia, Cremona, Piacenza and Rome, Italy

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

537

Predicted Citations

16,851

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I study (journal article) Berton, Dominique \| Pautier, Patricia \| Lorusso, Domenica \| Gennigens, Christine \| Gladieff, Laurence \| Kryzhanivska, Anna \| Bowman, Jill \| Tian, Chuan \| Cornfeld, Mark \| Van Gorp, Toon Gynecologic Oncology, volume 186 (2024). 10.1016/j.ygyno.2024.05.025 Cited by (1) \| Cite \| Source
Immunotherapy in MMR-d/MSI-H recurrent/metastatic endometrial cancer (journal article) Pacholczak-Madej, Renata \| Bartoletti, Michele \| Musacchio, Lucia \| Püsküllüoglu, Mirosława \| Blecharz, Paweł \| Lorusso, Domenica Expert Review of Anticancer Therapy (2024). 10.1080/14737140.2024.2367472 Cite \| Source
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients (journal article) Bruno, Matteo \| Apostol, Adriana Ionelia \| Boccia, Serena Maria \| Sassu, Carolina Maria \| Lardino, Sara \| Culcasi, Camilla \| Lorusso, Domenica \| Scambia, Giovanni \| Fagotti, Anna \| Marchetti, Claudia International Journal of Gynecologic Cancer (2024). 10.1136/ijgc-2024-005363 Cite \| Source
Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial (journal article) Coleman, Robert L \| Lorusso, Domenica \| Oaknin, Ana \| Cecere, Sabrina Chiara \| Denys, Hannelore \| Colombo, Nicoletta \| van Gorp, Toon \| Konner, Jason A \| Romeo Marin, Margarita \| Harter, Philipp \| ... \| Matulonis, Ursula International Journal of Gynecologic Cancer (2024). 10.1136/ijgc-2024-005401 Cited by (1) \| Cite \| Source
23O A randomized, phase III, double-blind study of chemoradiotherapy with or without pembrolizumab in patients with high-risk, locally advanced, cervical cancer (KEYNOTE-A18/ENGOT-cx11/GOG-3047): Results for patients enrolled in Asia (journal article) Xiang, Y. \| Hasegawa, K. \| Zhu, H. \| Zhou, Q. \| Zhang, X. \| Lee, J-Y. \| Usami, T. \| Zhao, W. \| Tharavichitkul, E. \| Suzuki, S. \| ... \| Lorusso, D. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103523 Cite \| Source
Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey (journal article) Mongelli, Michele \| Lorusso, Domenica \| Zanagnolo, Vanna \| Pignata, Sandro \| Colombo, Nicoletta \| Cormio, Gennaro Diagnostics, volume 14, issue 11, pages 1159- (2024). 10.3390/diagnostics14111159 Cite \| Source
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – a plain language summary (journal article) González-Martín, Antonio \| Pothuri, Bhavana \| Vergote, Ignace \| Graybill, Whitney \| Lorusso, Domenica \| McCormick, Colleen C \| Freyer, Gilles \| Backes, Floor \| Heitz, Florian \| Redondo, Andrés \| ... \| Monk, Bradley J Future Oncology (2024). 10.2217/fon-2023-0782 Cited by (1) \| Cite \| Source
Gynecological Cancer and Venous Thromboembolism: A Narrative Review to Increase Awareness and Improve Risk Assessment and Prevention (journal article) Falanga, Anna \| Lorusso, Domenica \| Colombo, Nicoletta \| Cormio, Gennaro \| Cosmi, Benilde \| Scandurra, Giuseppa \| Zanagnolo, Vanna \| Marietta, Marco Cancers, volume 16, issue 9, pages 1769- (2024). 10.3390/cancers16091769 Cited by (1) \| Cite \| Source
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis (journal article) Bartoletti, Michele \| Montico, Marcella \| Lorusso, Domenica \| Mazzeo, Roberta \| Oaknin, Ana \| Musacchio, Lucia \| Scambia, Giovanni \| Puglisi, Fabio \| Pignata, Sandro Cancer Treatment Reviews, volume 125 (2024). 10.1016/j.ctrv.2024.102701 Cited by (2) \| Cite \| Source
Best original research presented at the 24th European Congress on Gynaecological Oncology—Best of ESGO 2023 (journal article) Kacperczyk-Bartnik, Joanna \| Bizzarri, Nicolò \| Zwimpfer, Tibor Andrea \| El Hajj, Houssein \| Angeles, Martina Aida \| Tóth, Richard \| Theofanakis, Charalampos \| Bilir, Esra \| Gasimli, Khayal \| Strojna, Aleksandra Natalia \| ... \| Chiva, Luis International Journal of Gynecologic Cancer, volume 34, issue 4, pages 610-618 (2024). 10.1136/ijgc-2023-005132 Cited by (1) \| Cite \| Source
Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy (journal article) Rognoni, Carla \| Lorusso, Domenica \| Costa, Francesco \| Armeni, Patrizio Advances in Therapy, volume 41, issue 4, pages 1385-1400 (2024). 10.1007/s12325-024-02791-3 Cite \| Source
How BRCA and homologous recombination deficiency change therapeutic strategies in ovarian cancer: a review of literature (journal article) Arcieri, Martina \| Tius, Veronica \| Andreetta, Claudia \| Restaino, Stefano \| Biasioli, Anna \| Poletto, Elena \| Damante, Giuseppe \| Ercoli, Alfredo \| Driul, Lorenza \| Fagotti, Anna \| ... \| Vizzielli, Giuseppe Frontiers in Oncology, volume 14 (2024). 10.3389/fonc.2024.1335196 Cited by (6) \| Cite \| Source
#1056 Multi-omic characterization of naïve treatment samples of epithelial ovarian cancer addressed to neoadjuvant chemotherapy: an hypothesis-generating study on biomarkers of response to platinum-based chemotherapy (conference) Trozzi, Rita \| Mastrantoni, Luca \| Nero, Camilla \| Duranti, Simona \| Iacobelli, Valentina \| Minucci, Angelo \| Pasciuto, Tina \| Giacò, Luciano \| Zannoni, Gian Franco \| Giannarelli, Diana \| ... \| Scambia, Giovanni ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.1122 Cite \| Source
#556 Tolerability of the niraparib individualised starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy (conference) Vulsteke, Christof \| Chambers, Setsuko K \| Rubio Pérez, Maria Jesús \| Chan, John K \| Raaschou-Jensen, Nicoline \| Zhuo, Ying \| Lorusso, Domenica \| Herzog, Thomas J \| Rouge, Thibault De La Motte \| Thomes Pepin, Jessica A \| ... \| Monk, Bradley J ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.1128 Cite \| Source
733 Real world data of niraparib in platinum sensitive relapsed ovarian cancer: a multicenter experience of the MITO group (conference) Musacchio, Lucia \| Palluzzi, Eleonora \| Napoli, Marilena Di \| Lauria, Rossella \| Ferrandina, Gabriella \| Angioli, Roberto \| Bergamini, Alice \| Corrado, Giacomo \| Perniola, Giorgia \| Cassani, Chiara \| ... \| Lorusso, Domenica ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.703 Cite \| Source
360 Health-related quality of life in patients with FRα positive platinum-resistant ovarian cancer treated with mirvetuximab soravtansine vs. investigator’s choice chemotherapy: analysis from the phase 3 MIRASOL trial (conference) Garcia, Yolanda Garcia \| Gorp, Toon Van \| Konecny, Gottfried E \| Leary, Alexandra \| Santin, Alessandro D \| Crusz, Shanthini Mary \| Mantia-Smaldone, Gina \| Lorusso, Domenica \| Colombo, Nicoletta \| Thomes-Pepin, Jessica \| ... \| Moore, Kathleen N ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.43 Cite \| Source
1095 Management of paclitaxel associated hypersensitivity reactions in gynecological cancers: a single center retrospective analysis (conference) Carbone, Maria Vittoria \| Salutari, Vanda \| Ghizzoni, Viola \| Giudice, Elena \| Cannizzaro, Maria Chiara \| Lardino, Sara \| Musacchio, Lucia \| Camarda, Floriana \| Ricci, Caterina \| Petrecca, Alessandro \| ... \| Lorusso, Domenica ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.535 Cite \| Source
1199 Efficacy of bevacizumab versus PARP inhibitors as maintenance therapy after first-line platinum-based chemotherapy for homologous recombination proficient, advanced high-grade ovarian cancer patients: a retrospective study (conference) Giudice, Elena \| Vertechy, Laura \| Iannantuono, Giovanni Maria \| Petrecca, Alessandro \| Ghizzoni, Viola \| Sassu, Carolina Maria \| Ergasti, Raffaella \| Distefano, Mariagrazia \| Salutari, Vanda \| Lorusso, Domenica \| ... \| Marchetti, Claudia ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.800 Cite \| Source
New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere (journal article) Bruchim, Ilan \| Capasso, Ilaria \| Polonsky, Ariel \| Meisel, Shilhav \| Salutari, Vanda \| Werner, Haim \| Lorusso, Domenica \| Scambia, Giovanni \| Fanfani, Francesco Expert Opinion on Therapeutic Targets, volume 28, issue 1-2, pages 29-43 (2024). 10.1080/14728222.2024.2316739 Cited by (2) \| Cite \| Source
Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer (journal article) Tewari, Krishnansu S. \| Colombo, Nicoletta \| Monk, Bradley J. \| Dubot, Coraline \| Cáceres, M. Valeria \| Hasegawa, Kosei \| Shapira-Frommer, Ronnie \| Salman, Pamela \| Yañez, Eduardo \| Gümüş, Mahmut \| ... \| Lorusso, Domenica JAMA Oncology, volume 10, issue 2, pages 185- (2024). 10.1001/jamaoncol.2023.5410 Cited by (3) \| Cite \| Source